(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PP PLASMA PROTEIN THERAPEUTICS ASSOCIATION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PP PLASMA PROTEIN THERAPEUTICS ASSOCIATION

ST13

US500000098187544

Class

16, 35, 41

Filing

98187544

Registration

7618750

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

12/24/2024

Trademark type

Combined

Nice classes

16, 35, 41

Filing date

09/19/2023

Registration date

12/24/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/24/2024

Last transaction

12/24/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

04/30/2023

First use in commerce

04/30/2023

Drawing code

3

Owner type

06

Owner location

Annapolis, MD

Examiner

GILLANI, MAHREEN A

Law office

L90

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the literal element "PP" formed by two "P" shaped geometric shapes containing a curved geometric white band in between, followed by a vertical line and the wording "PLASMA PROTEIN THERAPEUTICS ASSOCIATION" on the right.

Holders and representatives

Holders

Plasma Protein Therapeutics Association

Representatives

Patricia L. Werner, Esq. KELLEY DRYE & WARREN LLP

Technical classification

Nice Classes

Class 16Class 35Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

printed matterpublications in the nature of booksbrochurespamphletsmagazinesnewsletters in the field of plasma protein therapeutics

Class 35

association servicespromoting the interests of the plasma protein therapeutics industry

Class 41

educational servicesproviding information about conferences and seminars in the field of plasma protein therapeutics to consumers and health care professionals via a global computer network

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/24/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/24/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/05/2024

PUBO

PUBLISHED FOR OPPOSITION

11/05/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/16/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

09/09/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/09/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

09/09/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/09/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

09/09/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

08/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/14/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

08/14/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/14/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

08/14/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/22/2024

GNRT

NON-FINAL ACTION E-MAILED

05/22/2024

CNRT

NON-FINAL ACTION WRITTEN

05/22/2024

DOCK

ASSIGNED TO EXAMINER

05/13/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/06/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/05/2023

NWAP

NEW APPLICATION ENTERED

09/22/2023

Continuous trademark protection

Get notified about every new filing that threatens PP PLASMA PROTEIN THERAPEUTICS ASSOCIATION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.